Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients
Clinical trial NCT04483284 · UNKNOWN
Trial details
- NCT number
- NCT04483284
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2024-12-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.